drugset / Trial / NCT02376114

Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma

NCT02376114

Phase 2 Completed 19 enrolled Maisonneuve-Rosemont Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

Glaucoma is one of the leading causes of blindness. Ginkgo biloba may be part of an effective treatment strategy for glaucoma because it has been shown to improve blood flow, it has antioxidant properties, it can relax smooth muscle, and it can protect neurons from damage. The goal of our study was to determine whether Ginkgo biloba would result in increased ocular blood flow which may protect against glaucoma damage.

Timeline

Start
2011-08
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 60 mg Oral

Indications